Non-Interventional Study on the Side Effects of Empagliflozin Compared with DPP-4 Inhibitors in Patients with Type 2 Diabetes in New Zealand

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Administrative healthcare records (e.g., claims)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No